Edition:
United States

Anatara Lifesciences Ltd (ANR.AX)

ANR.AX on Australia Stock Exchange

1.10AUD
8 Dec 2016
Change (% chg)

-- (--)
Prev Close
$1.10
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
--
52-wk High
--
52-wk Low
--

Summary

Name Age Since Current Position

Melvyn Bridges

65 2016 Chairman of the Board, Chief Executive Officer

Michael West

2016 Chief Operating Officer

David Hetzel

2014 Director

Tracie Ramsdale

2014 Director

Paul Grujic

2015 Non-Executive Director

Iain Ross

2014 Non-Executive Director

Biographies

Name Description

Melvyn Bridges

Michael West

Dr. Michael L. West is Chief Operating Officer of the Company. He has extensive global GMP manufacturing, regulatory and drug launch scale-up expertise, including experience with global drug company SmithKline Beecham (now GSK) in the USA, Alchemia Limited and the Centre for Drug Design & Development at the University of Queensland. Dr West has served on the Pharmaceutical subcommittee to the Australian Drug Evaluation Committee at the Therapeutic Goods Administration (TGA). Dr West will report directly to Dr Bridges and form part of the senior leadership team – also reporting to the board. Dr West will assume ownership for key areas of responsibility that have been managed to date by Dr Schober.

David Hetzel

Tracie Ramsdale

Paul Grujic

Paul Alexander Grujic is Non-Executive Director of Company. Mr Grujic was most recently the President of CSL Animal Health and a member of CSL’s Executive Committee and was responsible for CSL’s global animal health business with a staff of 250 and three manufacturing sites in Australia, the USA and New Zealand. He has also held senior positions in a number of global companies including Glaxo, Fort Dodge, American Cynamid, Pitman-Moore and Webster Animal Health. Mr Grujic also played leading roles in the sale of Catapult Genetics and CSL’s Animal Health business to global pharmaceutical company Pfizer. He was also involved in the sale of Peptech Animal Health to leading international animal health company Virbac.

Iain Ross

Basic Compensation

Name Fiscal Year Total

Melvyn Bridges

36,000

Michael West

--

David Hetzel

--

Tracie Ramsdale

--

Paul Grujic

--

Iain Ross

--
As Of  29 Jun 2014

Options Compensation